Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-03-09Clinical Trial Update: Haploid Allogeneic Transplant Using the CliniMACS System [Phase 2]
A Phase 2 clinical trial evaluating haploid allogeneic transplantation using the CliniMACS System was terminated, with results posted in 201…
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: S0528 Lapatinib and Everolimus in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 trial update of lapatinib combined with everolimus in patients with advanced solid tumors or Non-Hodgkin's lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-05Clinical Trial Update: Phase I/II Study of CAMPATH in Patients With Relapsing or Refractory Non-Hodgkin's Lymphoma [Phase 1, Phase 2]
Phase I/II trial of CAMPATH (alemtuzumab) in relapsed or refractory Non-Hodgkin lymphoma was terminated.
-
CLINICAL_TRIALS trial_result · 2015-02-25Clinical Trial Update: A Randomized Phase IIb Placebo-Controlled Study of R-ICE Chemotherapy With and Without SGN-40 for Patients With DLBCL [Phase 2]
A Phase IIb randomized trial evaluating R-ICE chemotherapy with and without SGN-40 for diffuse large B-cell lymphoma/non-Hodgkin lymphoma ha…
-
CLINICAL_TRIALS trial_result · 2015-02-18Clinical Trial Update: Rituximab, Combination Chemotherapy, and 90-Yttrium Ibritumomab Tiuxetan for Patients With Stage I or II Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 trial evaluating Rituximab with chemotherapy and 90-yttrium ibritumomab tiuxetan in patients with Stage I or II non-Hodgkin lympho…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-02-12Clinical Trial Update: Reduced Intensity Total Body Irradiation + Thymoglobulin Followed by Allogeneic PBSCT [Phase 2]
Phase 2 clinical trial evaluating reduced intensity total body irradiation plus Thymoglobulin followed by allogeneic peripheral blood stem c…
-
CLINICAL_TRIALS trial_result · 2015-02-11Clinical Trial Update: A Pilot Study to Evaluate the Co-Infusion of Ex Vivo Expanded Cord Blood Cells With an Unmanipulated Cord Blood Unit in Patients Undergoing Cord Blood Transplant for Hematologic Malignancies [Phase 1]
A Phase 1 pilot study evaluated co-infusing ex vivo expanded cord blood cells with an unmanipulated cord blood unit in patients undergoing c…
-
CLINICAL_TRIALS trial_result · 2015-02-11Clinical Trial Update: Pilot Study of Unrelated Cord Blood Transplantation [Phase 2]
Phase 2 pilot trial of unrelated cord blood transplantation sponsored by King's College Hospital NHS Trust has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-02-05Clinical Trial Update: Iodine I 131 Tositumomab Followed by Autologous Stem Cell Transplantation in Treating Older Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 2]
This clinical trial update describes a Phase 2 study of iodine-131 tositumomab followed by autologous stem cell transplantation. The study i…
-
CLINICAL_TRIALS trial_result · 2015-01-16Clinical Trial Update: Safety Study of the Bispecific T-cell Engager Blinatumomab (MT103) in Patients With Relapsed NHL [Phase 1]
Phase 1 safety study of blinatumomab (MT103), a bispecific T-cell engager, in patients with relapsed non-Hodgkin's lymphoma; results were po…
-
CLINICAL_TRIALS trial_result · 2015-01-15Clinical Trial Update: Safety and PK/PD of TG-0054 in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease Patients [Phase 2]
Phase 2 safety and PK/PD study of TG-0054 in patients with multiple myeloma, non-Hodgkin lymphoma, and Hodgkin disease has completed with re…
-
CLINICAL_TRIALS trial_result · 2015-01-13Clinical Trial Update: Study of Stem Cell Transplantation for Hematologic Malignancies Using Clofarabine and Busulfan Regimen [Phase 1, Phase 2]
This completed Phase 1/2 clinical trial evaluated a conditioning regimen using Clofarabine and Busulfan for hematologic malignancies, includ…
-
CLINICAL_TRIALS trial_result · 2015-01-08Clinical Trial Update: Study of MGCD0103 Given Three-Times Weekly in Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 trial of MGCD0103 (mocetinostat) given three times weekly in patients with advanced solid tumors or Non-Hodgkin's lymphoma has compl…
-
CLINICAL_TRIALS trial_result · 2015-01-08Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics, and Hematopoietic Stem Cell Mobilization of TG-0054 Alone or in Combination With G-CSF in Patients With Multiple Myeloma, Non-Hodgkin Lymphoma or Hodgkin Disease [Phase 2]
Phase 2 trial evaluating TG-0054 alone or with G-CSF in multiple myeloma and lymphomas; completed with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-01-07Clinical Trial Update: Study of SGN-40 in Patients With Relapsed Diffuse Large B-Cell Lymphoma [Phase 2]
A completed Phase 2 trial evaluating SGN-40 (dacetuzumab) in patients with relapsed diffuse large B-cell lymphoma and other non-Hodgkin lymp…
-
CLINICAL_TRIALS trial_result · 2014-12-30Clinical Trial Update: Study for Evaluation of Efficacy and Safety of SH L 749 to Indolent B-cell Non-Hodgkin's Lymphoma [Phase 2]
This document reports the completion of a Phase 2 clinical trial evaluating the efficacy and safety of SH-L-749 in indolent B-cell non-Hodgk…
-
CLINICAL_TRIALS trial_result · 2014-12-18Clinical Trial Update: Clinical Pharmacology Study of Brentuximab Vedotin (SGN-35) [Phase 1]
Phase 1 pharmacology study update of Brentuximab vedotin (SGN-35) has completed, according to clinical trials data. The study involves patie…
-
CLINICAL_TRIALS trial_result · 2014-12-18Clinical Trial Update: A Phase 1 Dose-escalation Trial of SGN-75 in CD70-positive Non-Hodgkin Lymphoma or Renal Cell Carcinoma [Phase 1]
Completed Phase 1 dose-escalation study of SGN-75 in CD70-positive non-Hodgkin lymphoma and renal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2014-12-18Clinical Trial Update: Phase I Open-Label Dose Finding Study of SGN-35 for CD30 Positive Hematologic Malignancies [Phase 1]
Phase I open-label dose-finding study of SGN-35 (brentuximab vedotin) for CD30-positive hematologic malignancies, including non-Hodgkin lymp…
-
CLINICAL_TRIALS trial_result · 2014-12-18Clinical Trial Update: Trial to Define the Safety and Tolerability of SGN-40, Rituximab, and Gemcitabine in Patients With DLBCL [Phase 1]
A Phase 1 trial assessed the safety and tolerability of combining SGN-40 (dacetuzumab) with rituximab and gemcitabine in patients with diffu…
-
CLINICAL_TRIALS trial_result · 2014-12-18Clinical Trial Update: A Safety Study of SGN-40 in Patients With Non-Hodgkin's Lymphoma [Phase 1]
A Phase 1 safety study of SGN-40 (brentuximab vedotin) in patients with Non-Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2014-12-18Clinical Trial Update: A Phase I Dose Escalation Study of SGN-35 Alone and in Combination With Gemcitabine for CD30-Positive Malignancies [Phase 1]
An early-phase Phase I dose-escalation study of Brentuximab vedotin (SGN-35) alone and in combination with gemcitabine for CD30-positive mal…
-
CLINICAL_TRIALS trial_result · 2014-12-12Clinical Trial Update: Cardiac Safety Study of Brentuximab Vedotin (SGN-35) [Phase 1]
Phase 1 cardiac safety study of brentuximab vedotin (SGN-35) has completed, providing early safety data in lymphoma patients.
-
CLINICAL_TRIALS trial_result · 2014-12-10Clinical Trial Update: Pilot Trial of Intravenous Vitamin C in Refractory Non-Hodgkin Lymphoma (NHL) [Phase 2]
A Phase 2 pilot trial evaluating intravenous vitamin C in patients with refractory non-Hodgkin lymphoma was terminated; results were posted …
-
CLINICAL_TRIALS trial_result · 2014-12-09Clinical Trial Update: Evaluation of Plerixafor Plus G-CSF to Mobilize and Collect 5×10^6CD34+ Cells/kg in Non-Hodgkin's Lymphoma (NHL) Patients for Autologous Transplantation [Phase 3]
A Phase 3 trial evaluating mobilization and collection of 5×10^6 CD34+ cells/kg in non-Hodgkin's lymphoma patients using a combination of pl…